Alan Horsager

Alan Horsager

Company: Duet Biotherapeutics

Job title: President & CEO


Bifunctional Oligonucleotides for Simultaneous Immune Activation & Reduction of Immunosuppression In the Tumor Microenvironment 2:30 pm

Duet reprograms the immune system to detect and eliminate cancer cells This is achieved by 1) activating the immune system via TLR9 stimulation and 2) simultaneously releasing immunosuppression in the tumor microenvironment through STAT3 inhibition Duet has three unique oligonucleotides moving through development that include siRNA, antisense, and decoy STAT3 inhibitorsRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.